Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment.
Seoane S, Arias E, Sigueiro R, Sendon-Lago J, Martinez-Ordoñez A, Castelao E, Eiró N, Garcia-Caballero T, Macia M, Lopez-Lopez R, Maestro M, Vizoso F, Mouriño A, Perez-Fernandez R.
Seoane S, et al.
Oncotarget. 2015 Jun 10;6(16):14456-71. doi: 10.18632/oncotarget.3894.
Oncotarget. 2015.
PMID: 25992773
Free PMC article.